{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:15:29Z","timestamp":1790741729480,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C12292\/A20861"],"award-info":[{"award-number":["C12292\/A20861"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C12292\/A22820"],"award-info":[{"award-number":["C12292\/A22820"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A7357"],"award-info":[{"award-number":["C5047\/A7357"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A3354"],"award-info":[{"award-number":["C5047\/A3354"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A10692"],"award-info":[{"award-number":["C5047\/A10692"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A15007"],"award-info":[{"award-number":["C5047\/A15007"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C5047\/A17528"],"award-info":[{"award-number":["C5047\/A17528"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prostate Research Campaign UK"},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Everyman Campaign"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.eururo.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T02:00:07Z","timestamp":1544234407000},"page":"834-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Homeobox B13 G84E Mutation and Prostate Cancer Risk"],"prefix":"10.1016","volume":"75","author":[{"given":"Tommy","family":"Nyberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koveela","family":"Govindasami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goska","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokhir","family":"Dadaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bancroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Ni Raghallaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisa","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romayne","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Rageevakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsofia","family":"Kote-Jarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind","family":"Eeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis C.","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.11.015_bib0225","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1242\/dev.00432","article-title":"Hoxb13 is required for normal differentiation and secretory function of the ventral prostate","volume":"130","author":"Economides","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.eururo.2018.11.015_bib0230","first-page":"193","article-title":"Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer","volume":"7","author":"Decker","year":"2014","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.eururo.2018.11.015_bib0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00439-012-1229-4","article-title":"HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)","volume":"132","author":"Xu","year":"2013","journal-title":"Hum Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0240","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ng.2437","article-title":"A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer","volume":"44","author":"Gudmundsson","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0245","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1158\/1055-9965.EPI-12-1000-T","article-title":"HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk","volume":"22","author":"Laitinen","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.11.015_bib0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eururo.2012.07.027","article-title":"A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk","volume":"65","author":"Karlsson","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0255","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bju.13416","article-title":"Prevalence of the HOXB13 G84E mutation in Danish men undergoing radical prostatectomy and its correlations with prostate cancer risk and aggressiveness","volume":"118","author":"Storebjerg","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.11.015_bib0260","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/annonc\/mdv004","article-title":"Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes","volume":"26","author":"Kote-Jarai","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0265","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/carcin\/bgt055","article-title":"The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial","volume":"34","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.eururo.2018.11.015_bib0270","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1158\/1055-9965.EPI-12-1154","article-title":"HOXB13 mutation and prostate cancer: studies of siblings and aggressive disease","volume":"22","author":"Witte","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.11.015_bib0275","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1158\/1055-9965.EPI-12-0495","article-title":"Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer","volume":"21","author":"Breyer","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.11.015_bib0280","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pros.22594","article-title":"The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland","volume":"73","author":"Klu\u017aniak","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2018.11.015_bib0285","doi-asserted-by":"crossref","first-page":"e54727","DOI":"10.1371\/journal.pone.0054727","article-title":"Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E","volume":"8","author":"MacInnis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2018.11.015_bib0290","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/pros.22604","article-title":"HOXB13 mutations in a population-based, case-control study of prostate cancer","volume":"73","author":"Stott-Miller","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2018.11.015_bib0295","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7150\/jca.11413","article-title":"Synonymous polymorphisms in HOXB13 as a protective factor for prostate cancer","volume":"6","author":"Albitar","year":"2015","journal-title":"J Cancer"},{"key":"10.1016\/j.eururo.2018.11.015_bib0300","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1158\/1055-9965.EPI-15-0247","article-title":"The HOXB13 G84E mutation is associated with an increased risk for prostate cancer and other malignancies","volume":"24","author":"Beebe-Dimmer","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.11.015_bib0305","doi-asserted-by":"crossref","first-page":"e1004930","DOI":"10.1371\/journal.pgen.1004930","article-title":"Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort","volume":"11","author":"Hoffmann","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0310","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.18632\/oncotarget.13646","article-title":"Whole exome sequencing in 75 high-risk families with validation and replication in independent case-control studies identifies TANGO2, OR5H14, and CHAD as new prostate cancer susceptibility genes","volume":"8","author":"Karyadi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2018.11.015_bib0315","doi-asserted-by":"crossref","first-page":"17778","DOI":"10.1038\/s41598-017-18217-w","article-title":"Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours","volume":"7","author":"FitzGerald","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2018.11.015_bib0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.23453","article-title":"Genetic factors influencing prostate cancer risk in Norwegian men","volume":"78","author":"Chen","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2018.11.015_bib0325","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJMoa1110000","article-title":"Germline mutations in HOXB13 and prostate-cancer risk","volume":"366","author":"Ewing","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.11.015_bib0330","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djs288","article-title":"Association between germline HOXB13 G84E mutation and risk of prostate cancer","volume":"104","author":"Akbari","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2018.11.015_bib0335","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/aje\/148.7.623","article-title":"The kin-cohort study for estimating penetrance","volume":"148","author":"Wacholder","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0340","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(05)67570-8","article-title":"Population-based family studies in genetic epidemiology","volume":"366","author":"Hopper","year":"2005","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.eururo.2018.11.015_bib0345","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.11.015_bib0350","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1034\/j.1399-0004.2003.00038.x","article-title":"Genetic counseling for prostate cancer risk","volume":"63","author":"Nieder","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0355","doi-asserted-by":"crossref","first-page":"509","DOI":"10.6004\/jnccn.2016.0060","article-title":"NCCN guidelines insights: prostate cancer early detection, version 2.2016","volume":"14","author":"Carroll","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.eururo.2018.11.015_bib0360","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2017.74.1173","article-title":"Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017","volume":"36","author":"Giri","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0365","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2013.03.007","article-title":"Germline homeobox B13 (HOXB13) G84E mutation and prostate cancer risk in European descendants: a meta-analysis of 24,213 cases and 73, 631 controls","volume":"64","author":"Shang","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0370","doi-asserted-by":"crossref","first-page":"67101","DOI":"10.18632\/oncotarget.11937","article-title":"Association between germline homeobox B13 (HOXB13) G84E allele and prostate cancer susceptibility: a meta-analysis and trial sequential analysis","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2018.11.015_bib0375","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1399-0004.1977.tb00928.x","article-title":"Ascertainment in the sequential sampling of pedigrees","volume":"12","author":"Cannings","year":"1977","journal-title":"Clin Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0380","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/1055-9965.EPI-16-0106","article-title":"The OncoArray Consortium: a network for understanding the genetic architecture of common cancers","volume":"26","author":"Amos","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.11.015_bib0385","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0390","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2307\/1426718","article-title":"Probability functions on complex pedigrees","volume":"10","author":"Cannings","year":"1978","journal-title":"Adv Appl Probab"},{"key":"10.1016\/j.eururo.2018.11.015_bib0395","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/genetics\/147.3.1423","article-title":"An approximate model of polygenic inheritance","volume":"147","author":"Lange","year":"1997","journal-title":"Genetics"},{"key":"10.1016\/j.eururo.2018.11.015_bib0400","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2018.11.015_bib0405","first-page":"387","article-title":"A resolution of the ascertainment sampling problem. III. Pedigrees","volume":"43","author":"Shute","year":"1988","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0410","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/bioinformatics\/btt187","article-title":"Mendel: the Swiss army knife of genetic analysis programs","volume":"29","author":"Lange","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.eururo.2018.11.015_bib0415","series-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2017"},{"key":"10.1016\/j.eururo.2018.11.015_bib0420","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/gepi.20433","article-title":"Prostate cancer segregation analyses using 4390 families from UK and Australian population-based studies","volume":"34","author":"MacInnis","year":"2010","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.eururo.2018.11.015_bib0425","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1136\/bmj.309.6965.1351","article-title":"Why sources of heterogeneity in meta-analysis should be investigated","volume":"309","author":"Thompson","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2018.11.015_bib0430","doi-asserted-by":"crossref","first-page":"e27130","DOI":"10.1371\/journal.pone.0027130","article-title":"An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis","volume":"6","author":"Kici\u0144ski","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2018.11.015_bib0435","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nrg3786","article-title":"The contribution of genetic variants to disease depends on the ruler","volume":"15","author":"Witte","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.eururo.2018.11.015_bib0440","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.292.12.1480","article-title":"Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history","volume":"292","author":"Murff","year":"2004","journal-title":"JAMA"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818308728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818308728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:06:30Z","timestamp":1759583190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818308728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0302283818308728"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.11.015","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homeobox B13 G84E Mutation and Prostate Cancer Risk","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}